BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38175664)

  • 1. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of Machine Learning Models for Predicting Occult Nodal Metastasis in Early-Stage Oral Cavity Squamous Cell Carcinoma.
    Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde SL; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
    JAMA Netw Open; 2022 Apr; 5(4):e227226. PubMed ID: 35416990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma.
    Carey RM; Anagnos VJ; Prasad A; Sangal NR; Rajasekaran K; Shanti RM; Cannady SB; Newman JG; Brant JA; Brody RM
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):348-359. PubMed ID: 37967536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Margin Assessment Methods in Oral Cavity Squamous Cell Carcinoma and Recurrence: Tumor Bed vs Resection Specimen Sampling.
    Wu SS; Woody N; Hesse J; Cook S; Cracolici V; Ku JA; Prendes B; Silver N; Scharpf J; Brauer PR; Reddy CA; Campbell SR; Koyfman SA; Burkey B; Lamarre ED
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1011-1020. PubMed ID: 37768650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.
    Robinson EM; Lam AS; Solomon I; Brady JS; Pang J; Faraji F; Houlton JJ; Futran ND; Barber BR
    Laryngoscope; 2022 Oct; 132(10):1962-1970. PubMed ID: 35102568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
    Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indication to post-operative radiotherapy for oral cavity squamous cell carcinoma: what's new in the depth of infiltration (DOI) era?
    Alterio D; De Berardinis R; Augugliaro M; D'Urso P; Volpe S; Maffini F; Bruschini R; Marvaso G; Riccio S; Tagliabue M; Turturici I; Farneti A; Calabrese L; StarzyƄska A; Ferrari A; Zaffaroni M; Jereczek-Fossa BA; Sanguineti G; Ansarin M
    Br J Radiol; 2022 Apr; 95(1132):20210705. PubMed ID: 34919446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of smoking on pathological features in oral cavity squamous cell carcinoma.
    Al Feghali KA; Ghanem AI; Burmeister C; Chang SS; Ghanem T; Keller C; Siddiqui F
    J Cancer Res Ther; 2019; 15(3):582-588. PubMed ID: 31169224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
    Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcategorization of Perineural Invasion Stratifies Oral Cavity Squamous Cell Carcinoma Prognosis.
    Fung N; Fleseriu CM; Harley RJ; Khan NI; Kim S
    Laryngoscope; 2024 Apr; 134(4):1656-1662. PubMed ID: 37772957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the seventh and eighth edition american joint committee on cancer oral cavity staging systems.
    Cramer JD; Reddy A; Ferris RL; Duvvuri U; Samant S
    Laryngoscope; 2018 Oct; 128(10):2351-2360. PubMed ID: 29658104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment.
    Lee NCJ; Eskander A; Park HS; Mehra S; Burtness BA; Husain Z
    Cancer; 2019 Sep; 125(17):2975-2983. PubMed ID: 31090934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcome in Advanced Oral Squamous Cell Carcinoma After Refusal of Recommended Adjuvant Therapy.
    Mrosk F; Doll C; Scheer J; Neumann F; Hofmann E; Kreutzer K; Voss J; Rubarth K; Beck M; Heiland M; Koerdt S
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1027-1033. PubMed ID: 37824130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases.
    Zhan KY; Morgan PF; Neskey DM; Kim JJ; Huang AT; Garrett-Mayer E; Day TA
    Head Neck; 2018 Sep; 40(9):1967-1976. PubMed ID: 29761586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
    Dermody SM; McMichael BM; Bellile E; Marchiano EJ; Chinn SB
    Oral Oncol; 2023 Nov; 146():106572. PubMed ID: 37742470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.
    Prasad K; Topf MC; Clookey S; Philips R; Curry J; Tassone P
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1200-1207. PubMed ID: 37232479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.